The Technical Analyst
Select Language :
Regulus Therapeutics Inc [RGLS]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Regulus Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Regulus Therapeutics Inc is listed at the  Exchange

0.00% $2.88

America/New_York / 28 mar 2024 @ 16:00


Regulus Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 188.54 mill
EPS: -1.580
P/E: -1.820
Earnings Date: May 08, 2024
SharesOutstanding: 65.47 mill
Avg Daily Volume: 3.07 mill
RATING 2024-03-28
B-
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Neutral
P/E: Sell
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -1.820 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.31x
Company: PE -1.820 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$1.093
(-62.04%) $-1.787
Date: 2024-03-29
Expected Trading Range (DAY)

$ 2.78 - 2.98

( +/- 3.51%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-14 Papadopoulos Stelios Buy 250 000 Common Stock
2024-01-18 Calsada Crispina Sell 5 468 Common Stock
2024-01-18 Aker Christopher Ray Sell 5 468 Common Stock
2024-01-18 Hagan Joseph P Sell 14 580 Common Stock
2024-01-12 Klassen Preston Buy 120 000 Stock Option (Right to Buy)
INSIDER POWER
98.58
Last 86 transactions
Buy: 13 400 605 | Sell: 39 678

Forecast: 16:00 - $2.89

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $2.89
Forecast 2: 16:00 - $2.89
Forecast 3: 16:00 - $2.89
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $2.88 (0.00% )
Volume 0.808 mill
Avg. Vol. 3.07 mill
% of Avg. Vol 26.33 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Regulus Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Regulus Therapeutics Inc

RSI

Intraday RSI14 chart for Regulus Therapeutics Inc

Last 10 Buy & Sell Signals For RGLS

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Regulus Therapeutics Inc

RGLS

Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS8429, an anti-miR targeting miR-17, which is in Phase 1b clinical study for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Last 10 Buy Signals

Date Signal @
SUPERUSDMar 29 - 09:34$1.359
UQCUSDMar 29 - 06:54$7.20
BNBUSDMar 29 - 09:31$615.19
TIMEUSDMar 29 - 09:3232.37
AGLDUSDMar 29 - 09:301.650
MINAUSDMar 29 - 09:29$1.238
CBKUSDMar 29 - 09:281.087
METAMar 28 - 16:00$485.58
MSTRMar 28 - 16:00$1 704.56
STORJUSDMar 29 - 09:26$0.817

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.